FRONTLINE® Wins Brand of the Year Award for the Third Time in a row

Boehringer Ingelheim, a global leader in animal health, is proud to announce that the World Branding Forum has once again recognized FRONTLINE® with its prestigious Brand of the Year award (Animalis Edition) for 2023-2024. This marks the third time FRONTLINE® has received this accolade, having previously won the award in 2021-2022 and 2019-2020.

The Brand of the Year award honors outstanding brands that demonstrate excellence in innovation, customer satisfaction, and overall performance. FRONTLINE®’s continued success in these areas highlights Boehringer Ingelheim’s unwavering commitment to pet owners and the animals the company serves.

The World Branding Awards are organized by the World Branding Forum, a global non-profit organisation dedicated to advancing branding standards. Winners are judged through three streams: brand valuation, consumer market research, and public online voting. Over 100,000 consumers from around the world voted for their favorite brands, in 32 countries, across 5 continents. This year, more than 1,500 brands were nominated by the public, but only 100 won “Brand of the Year”.

"We would like to extend our heartfelt thanks to the consumers who voted for FRONTLINE®, showing support and their trust in our flagship brand," said Michael Horn, Global Head of Pet Parasiticides at Boehringer Ingelheim. "This award is a testament to the hard work and dedication of our teams, who consistently strive to delight pet owners and to deliver the best possible solutions to protect pets against parasites."

World Branding Forum

The World Branding Forum (WBF) is a global, non-profit organization dedicated to advancing branding standards for the good of the branding community as well as consumers. This includes those who work in the branding, design, marketing, advertising, public relations and communications disciplines worldwide. The WBF produces, manages and supports a wide range of programmes covering research, development, education, recognition, networking and outreach. For more information, visit brandingforum.org.

Boehringer Ingelheim Animal Health

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, farmers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. As a global leader in the animal health industry and as part of family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both. For more information visit: https://www.boehringer-ingelheim.com/animal-health

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com  

Boehringer Ingelheim’s Intended Audiences Notice

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.